BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 9758696)

  • 1. The impact of variation in the number of CD8(+) T-cell precursors on the outcome of virus infection.
    Ehl S; Klenerman P; Zinkernagel RM; Bocharov G
    Cell Immunol; 1998 Oct; 189(1):67-73. PubMed ID: 9758696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo state of antiviral CTL precursors. Characterization of a cycling cell population containing CTL precursors in immune mice.
    Razvi ES; Welsh RM; McFarland HI
    J Immunol; 1995 Jan; 154(2):620-32. PubMed ID: 7529281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modelling the dynamics of LCMV infection in mice: conventional and exhaustive CTL responses.
    Bocharov GA
    J Theor Biol; 1998 Jun; 192(3):283-308. PubMed ID: 9650288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells.
    Moskophidis D; Lechner F; Pircher H; Zinkernagel RM
    Nature; 1993 Apr; 362(6422):758-61. PubMed ID: 8469287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Memory CD8+ T cells in heterologous antiviral immunity and immunopathology in the lung.
    Chen HD; Fraire AE; Joris I; Brehm MA; Welsh RM; Selin LK
    Nat Immunol; 2001 Nov; 2(11):1067-76. PubMed ID: 11668342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD40 ligand is pivotal to efficient control of virus replication in mice infected with lymphocytic choriomeningitis virus.
    Thomsen AR; Nansen A; Christensen JP; Andreasen SO; Marker O
    J Immunol; 1998 Nov; 161(9):4583-90. PubMed ID: 9794385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protracted course of lymphocytic choriomeningitis virus WE infection in early life: induction but limited expansion of CD8+ effector T cells and absence of memory CD8+ T cells.
    Belnoue E; Fontannaz-Bozzotti P; Grillet S; Lambert PH; Siegrist CA
    J Virol; 2007 Jul; 81(14):7338-50. PubMed ID: 17494081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining parameters for successful immunocytotherapy of persistent viral infection.
    Berger DP; Homann D; Oldstone MB
    Virology; 2000 Jan; 266(2):257-63. PubMed ID: 10639312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired anti-viral T cell responses due to expression of the Ly49A inhibitory receptor.
    Zajac AJ; Vance RE; Held W; Sourdive DJ; Altman JD; Raulet DH; Ahmed R
    J Immunol; 1999 Nov; 163(10):5526-34. PubMed ID: 10553080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD40-CD40 ligand costimulation is required for generating antiviral CD4 T cell responses but is dispensable for CD8 T cell responses.
    Whitmire JK; Flavell RA; Grewal IS; Larsen CP; Pearson TC; Ahmed R
    J Immunol; 1999 Sep; 163(6):3194-201. PubMed ID: 10477587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection of CD3 delta knockout mice from lymphocytic choriomeningitis virus-induced immunopathology: implications for viral neuroinvasion.
    Kappes DJ; Lawrence DM; Vaughn MM; Davé VP; Belman AR; Rall GF
    Virology; 2000 Apr; 269(2):248-56. PubMed ID: 10753703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes.
    von Herrath MG; Coon B; Lewicki H; Mazarguil H; Gairin JE; Oldstone MB
    J Immunol; 1998 Nov; 161(9):5087-96. PubMed ID: 9794447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early antibodies specific for the neutralizing epitope on the receptor binding subunit of the lymphocytic choriomeningitis virus glycoprotein fail to neutralize the virus.
    Eschli B; Zellweger RM; Wepf A; Lang KS; Quirin K; Weber J; Zinkernagel RM; Hengartner H
    J Virol; 2007 Nov; 81(21):11650-7. PubMed ID: 17699567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor cell persistence and activation-induced unresponsiveness of peripheral CD8+ T cells.
    Ehl S; Barchet W; Oehen S; Aichele P; Hombach J; Hengartner H; Zinkernagel RM
    Eur J Immunol; 2000 Mar; 30(3):883-91. PubMed ID: 10741405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective antiviral cytotoxic T cell memory is most efficiently maintained by restimulation via dendritic cells.
    Ludewig B; Oehen S; Barchiesi F; Schwendener RA; Hengartner H; Zinkernagel RM
    J Immunol; 1999 Aug; 163(4):1839-44. PubMed ID: 10438917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic identification of antigen-dependent and antigen-independent CD8 CTL precursors in the draining lymph node during acute cutaneous herpes simplex virus type 1 infection.
    McNally JM; Dempsey D; Wolcott RM; Chervenak R; Jennings SR
    J Immunol; 1999 Jul; 163(2):675-81. PubMed ID: 10395657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD40 ligand-mediated interactions are involved in the generation of memory CD8(+) cytotoxic T lymphocytes (CTL) but are not required for the maintenance of CTL memory following virus infection.
    Borrow P; Tough DF; Eto D; Tishon A; Grewal IS; Sprent J; Flavell RA; Oldstone MB
    J Virol; 1998 Sep; 72(9):7440-9. PubMed ID: 9696840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective immunity from naive CD8+ T cells activated in vitro with MHC class I binding immunogenic peptides and IL-2 in the absence of specialized APCs.
    Hauser C; Zipprich F; Leblond I; Wirth S; Hügin AW
    J Immunol; 1999 Jul; 163(1):330-6. PubMed ID: 10384132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Commentary: T cells get by with a little help from their friends.
    Klenerman P
    Eur J Immunol; 2004 Feb; 34(2):313-6. PubMed ID: 14768035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel approach to visualize polyclonal virus-specific CD8 T cells in vivo.
    Zimmermann C; Pircher H
    J Immunol; 1999 May; 162(9):5178-82. PubMed ID: 10227990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.